|
Center for Drug Evaluation &
Research (CDER) News
Drug
Approvals -
Meetings
-
Links |
Center for Biologics Evaluation
& Research (CBER)
Meetings
-
Links |
Center for Device &
Radiological Health (CDRH)
Meetings
-
Links |
Federal Register - Meetings,
Notices, & Rule Changes |
|
CDER NEWS |
February 26,
2010
February 25,
2010
February 24,
2010
February 23,
2010
February 22,
2010
|
|
|
February 25,
2010
-
Bystolic
(nebivolol
hydrochloride)
Tablets,
Forest
Laboratories,
Inc.,
Efficacy
Supplement
-
Cayston
(aztreonam)
Inhalation
Solution,
Gilead
Sciences,
Inc.,
Approval
-
Cefoxitin
and
Dextrose
in
Duplex
Container
Injection,
B. Braun
Medical,
Inc.,
Labeling
Revision
-
Cyanokit
(hydroxocobalamin)
Injection,
Merck
Sante
s.a.s.,
Labeling
Revision
-
Dyazide
(hydrochlorothiazide
and
triamterene)
Capsules,
GlaxoSmithKline,
Labeling
Revision
-
Finasteride
Tablets,
Accord
Healthcare,
Inc.,
Approval
-
Forane
(isoflurane)
Inhalation
Liquid,
Baxter
Healthcare
Corporation,
Labeling
Revision
-
Imiquimod
Cream,
Nycomed,
Inc.,
Approval
-
Intelence
(etravirine)
Tablets,
Tibotec,
Inc.,
Labeling
Revision
-
Marcaine
(bupivacaine
hydrochloride)
Injection,
Hospira,
Inc.,
Labeling
Revision
-
Marcaine
(bupivacaine
hydrochloride)
Injection,
Hospira,
Inc.,
Labeling
Revision
-
Naratripta
Tablets,
Roxane
Laboratories,
Inc.,
Tentative
Approval
-
Niaspan
(niacin)
Extended-Release
Tablets,
Abbott
Laboratories,
Labeling
Revision
-
Norethindrone
and
Ethinyl
Estradiol
Tablets,
Watson
Laboratories,
Inc.,
Approval
-
Polyethylene
Glycol
3350 and
Electrolytes
Oral
Solution,
Paddock
Laboratories,
Approval
-
Rocaltrol
(calcitriol)
Capsules,
Validus
Pharmaceuticals,
Labeling
Revision
-
Septocaine
(articaine
hydrochloride
and
epinephrine)
Injection,
Deproco,
Inc.,
Labeling
Revision
-
Tamiflu
(oseltamivir
phosphate)
Capsules,
Hoffmann-La
Roche,
Inc.,
Labeling
Revision
and
Efficacy
Supplement
-
Tamiflu
(oseltamivir
phosphate)
Oral
Suspension,
Hoffmann-La
Roche,
Inc.,
Labeling
Revision
and
Efficacy
Supplement
-
Tracleer
(bosentan)
Tablets,
Actelion,
Ltd.,
Labeling
February 24,
2010
-
Carbocaine
(mepivacaine
hydrochloride)
Injection,
Hospira,
Inc.,
Labeling
Revision
-
Desloratadine
Tablets,
Orchid
Healthcare,
Approval
-
Mirapex
ER (pramipexole
dihydrochloride)
Extended-Release
Tablets,
Boehringer
Ingelheim
Pharmaceuticals,
Inc.,
Approval
-
Naropin
(ropivacaine
hydrochloride
monohydrate)
Injection,
APP
Pharmaceuticals,
Labeling
Revision
-
Nesacaine
(chloroprocaine
hydrochloride)
Injection,
APP
Pharmaceuticals,
Labeling
Revision
-
Xylocaine
(lidocaine
hydrochloride)
Injection,
APP
Pharmaceuticals,
Labeling
Revision
-
Xylocaine
4%
Preservative
Free
(lidocaine
hydrochloride)
Injection,
APP
Pharmaceuticals,
Labeling
Revision
February 23,
2010
-
Alendronate
Sodium
Tablets,
Cadista
Pharmaceuticals
Inc.,
Approval
-
Baclofen
Tablets,
Matrix
Laboratories
Ltd.,
Approval
-
Caduet
(amlodipine
besylate
and
atorvastatin
calcium)
Tablets,
Pfizer,
Inc.,
Labeling
Revision
-
Ciclopirox
Topical
Solution,
VersaPharm
Inc.,
Approval
-
Coartem
(artemether
and
lumefantrine)
Tablets,
Novartis
Pharmaceuticals
Corp.,
Labeling
Revision
-
Donepezil
Hydrochloride
Tablets,
Torrent
Pharmaceuticals
Ltd.,
Tentative
Approval
-
Metformin
Hydrochloride
Extended-Release
Tablets,
Torrent
Pharmaceuticals
Ltd.,
Approval
|
|
|
-
DIA/FDA
CDER/CBER
Computational
Science
Annual
Meeting,
March
22-23,
2010,
Bethesda,
MD.
Meeting
information
and
registration
-
AASLD/FDA/PhRMA
Drug-Induced
Liver
Injury:
Getting
the
Medicine
and
Science
Together,
March
24-25,
2010,
Silver
Spring,
MD.
Meeting
information
and
registration
-
4th
Annual
FDA/DIA
Statistics
Forum,
April
19-21,
2010,
Bethesda,
MD.
Meeting
information
and
registrat
-
FDA and
PAT for
Pharma
Manufacturing:
FDA-Partnering
with
Industry;
a joint
FDA/URI
College
of
Pharmacy
conference,
Bethesda,
Maryland,
Hyatt
Regency
Bethesda,
May
11-12,
2010.
Meeting
information
and
registration
|
|
|
|
Guidance
Approved Drugs
Approval Process
Electronic Submissions
Firm Registration Status
Good Manufacturing Practice
Regulations
National Drug Code Directory
MedWatch: Adverse Event
Reporting
Download Forms
Generic Drugs
Small Business
En
Espaρol
|
|
|
CBER NEWS |
- 2009 Biological New Drug Application (NDA) and Abbreviated New Drug Application (ANDA) Approvals
Updated: 2/26/2010
- 2009 Biological Device Application Approvals
Updated: 2/26/2010
- 2009 Biological License Application Supplement Noteworthy Approvals
Updated: 2/26/2010
- 2010 Biological Device Application Approvals
Updated: 2/26/2010
- FluMist
Package Insert Updated, Posted: 2/26/2010
- Jobs at the Center for Biologics Evaluation and Research (CBER)
Nurse Consultant (Direct Hire), Posted: 2/26/2010
- Jobs at the Center for Biologics Evaluation and Research (CBER)
Program Analyst, OM/DPEB, Posted: 2/25/2010
- Prevnar 13
Product Approval, Posted: 2/24/2010
- Influenza A (H1N1) 2009 Monovalent Vaccines Composition and Lot Release
Lot Release Information, Updated: 2/24/2010
- Infanrix
Revise the Package Insert to add a warning regarding apnea in premature infants. Posted: 2/24/2010
- ROTARIX
Revise the Contraindications section to include infants with Severe Combined Immunodeficiency Disease (SCID), Posted: 2/23/2010
- Jobs at the Center for Biologics Evaluation and Research (CBER)
Posted: 2/23/2010
- FDA Public Health Notification: Newborn Blood Banking, Inc.
Posted: 2/23/2010
- Order to Cease Manufacturing of HCT/Ps: Newborn Blood Banking, Inc.
Posted: 2/23/2010
- NovoSevenRT
Package Insert Update, Posted: 2/23/2010
- Biologics PREA Reviews and Labeling Changes
Menveo information added, Updated: 2/22/2010
- Jobs at the Center for Biologics Evaluation and Research (CBER)
Regulatory Information Specialist, OCBQ, Posted: 2/22/2010
- Jobs at the Center for Biologics Evaluation and Research (CBER)
Mathematical Statistician, General Register, Posted: 2/22/2010
|
|
|
|
|
|
|
|
About CBER
CBER Vision & Mission Biologics Research, Regulatory Information, Safety & Availability, Guidances, Development & Approval, Enforcement & Compliance
News & Events (Biologics) What's New, Meetings & Workshops
CBER Reports CBER Annual Report, Performance, FDAMA, PDUFA, FDAAA, PREA
Biologics Regulated Products Allergenics, Blood & Blood Products, Cellular & Gene Therapy Products, Tissue & Tissue Products, Vaccines, Xenotransplantation
Contacts in the Center for Biologics Evaluation & Research (CBER) Consumer questions, manufacturer's assistance, media inquiries, technical questions, requesting speakers, establishment registration...
Jobs at the Center for Biologics Evaluation and Research (CBER)
Frequently Asked Questions about the Center for Biologics Evaluation and Research (CBER) and the Products CBER Regulates
Biologics Electronic Reading Room (eFOI) Documents frequently requested through the Freedom of Information Act.
|
|
|
|
|
|
|
|
RULES - NONE |
|
|
NOTICES
|
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals:
Mental Models Study of Recruitment and Retention of
Pregnant Women Into An
Asthma Pregnancy Registry
89578959 [20103912]
[TEXT] [PDF]
Reporting and Recordkeeping Requirements and
Availability of Sample
Electronic Products for
Manufacturers and
Distributors of Electronic
Products
89638966 [20104002]
[TEXT] [PDF]
Substances Prohibited From Use in Animal Food or Feed;
Animal Proteins Prohibited
in Ruminant Feed
89598960 [20103911]
[TEXT] [PDF]
Third Party Disclosure and Recordkeeping Requirements
for Reportable Food
89608963 [20104003]
[TEXT] [PDF]
Draft Guidance for Industry:
Adaptive Design Clinical Trials for Drugs and
Biologics; Availability
89688970 [20103980]
[TEXT] [PDF]
Guidance for Industry on
Submission of Documentation:
Applications for Parametric Release of Human and Veterinary
Drug Products Terminally
Sterilized by Moist Heat
Processes
89708971 [20103978]
[TEXT] [PDF]
|
|
|
|
RULES - NONE |
|
|
NOTICES - NONE |
|
|
|
|
RULES - NONE |
|
|
NOTICES |
Meetings:
Advisory Committee for Pharmaceutical Science and
Clinical Pharmacology
83688369 [20103594]
[TEXT] [PDF]
Device Improvements to Reduce Unnecessary Radiation
Exposure from Medical
Imaging; Request for
Comments
83758377 [20103674]
[TEXT] [PDF]
Pulmonary-Allergy Drugs Advisory Committee
8377 [20103595]
[TEXT] [PDF]
|
|
|
|
RULES - NONE |
|
|
NOTICES |
Debarment Orders:
Patrick J. Lais
80818082 [20103552]
[TEXT] [PDF]
Preventive Controls for
Fresh Produce; Request for
Comments
80868087 [20103409]
[TEXT] [PDF]
|
|
|
|
RULES |
New Animal Drugs for Use in
Animal Feeds:
Bacitracin Zinc; Nicarbazin
7555 [20103328]
[TEXT] [PDF]
|
|
NOTICES |
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals:
Experimental Study of Graphic Cigarette Warning Labels
76047606 [20103320]
[TEXT] [PDF]
Request for Environmental
Impact Data and Information:
Safety and Efficacy Review for Additional Ingredients
in Over-the-Counter Drug
Products for Human Use
76067608 [20103319]
[TEXT] [PDF]
|
|
|
|
|
|
|
-
- February 26, 2010 -
International Collaboration: FDA and European Medicines Agency Agree to
Accept a Single Orphan Drug Designation Annual Report
- February 26, 2010 -
FDA Update on the Investigation into the Salmonella Montevideo Outbreak -
February 26, 2010
- February 26, 2010 -
FDA Approves Therapy to Treat Gaucher Disease
- February 26, 2010 -
U.S. Attorney News Release: Medical Device Manufacturer Guidant Charged in
Failure to Report Defibrillator Safety
- February 25, 2010 -
FDA Update on the Investigation into the Salmonella Montevideo Outbreak -
February 25, 2010
- February 25, 2010 -
U.S. Attorney News Release: Medical Technician Sentenced to 30 Years
- February 24, 2010 -
FDA Approves Pneumococcal Disease Vaccine with Broader Protection
- February 24, 2010 -
NIH and FDA Announce Collaborative Initiative to Fast-track Innovations to
the Public
- February 23, 2010 -
U.S. Attorney News Release: Woman pleads guilty to poisoning salsa at Lenexa
restaurant
- February 23, 2010 -
FDA Announces Possible Safety Concern for HIV Drug Combination
- February 23, 2010 -
Maryland Veal Calf Dealer Agrees to Close in Response to FDA-Initiated
Action
- February 19, 2010 -
Regulatory Science Update: FDA and International Serious Adverse Events
Consortium Complete Third Data Release
- February 19, 2010 -
U.S. Attorney New Release: Miami Prescription Drug Diverter Sentenced To 70
Months In Prison
- February 19, 2010 -
U.S. Attorney New Release: SK Foods former owner charged with RICO
violations
- February 18, 2010 -
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
- February 18, 2010 -
FDA Cancer Drug Approval Rate Highlighted in JNCI
- February 18, 2010 -
USDA and FDA Coordinating Efforts to Ensure Safety of Produce
- February 18, 2010 -
FDA Announces New Safety Controls for Long-Acting Beta Agonists, Medications
Used to Treat Asthma
- February 17, 2010 -
FDA Warns about Serious Side Effects from Maalox Product Mix-Ups
- February 17, 2010 -
FDA Update on the Investigation into the Salmonella Montevideo Outbrea
- February 16, 2010 -
FDA Announces New Safety Plan for Agents Used to Treat Chemotherapy-Related
Anemia
- February 12, 2010 -
U.S. Attorney News Release: Company pleads guilty to felony misbranding of a
drug
- February 12, 2010 -
U.S. Attorney News Release: Subject sentenced to 51 months for sale of
unapproved medical devices
- February 12, 2010 -
U.S. Attorney New Release: Business Owner Pleads Guilty to Fraudulently
Marketing Dietary Supplements
- February 09, 2010 -
FDA Approves New Indication for Crestor
- February 09, 2010 -
FDA Unveils Initiative to Reduce Unnecessary Radiation Exposure from Medical
Imaging
- February 08, 2010 -
FDA Updates Statement on the Investigation into the Salmonella Montevideo
Outbreak
- February 05, 2010 -
FDA Issues Guidance to Help Streamline Medical Device Clinical Trials
- February 03, 2010 -
United States Seizes more than 1500 Cases of Food from Wisconsin
Distribution Warehouse
- February 02, 2010 -
FDA Approves Xiaflex for Debilitating Hand Condition
- February 01, 2010 -
FDA Requests $4.03 Billion to Transform Food Safety System, Invest in
Medical Product Safety, Regulatory Science
- February 01, 2010 -
FDA Announces Safety Risk Associated with HIV Drug
- February 01, 2010 -
FDA Collaboration Seeks to Speed Development of Pneumococcal Vaccines for
Children in Developing Countries
- January 29, 2010 -
FDA Statement on the Investigation into the Salmonella Montevideo Outbreak
- January 29, 2010 -
FDA Expands Use of Approved Breast Cancer Drug
- January 29, 2010 -
United States Seizes Unapproved Ozone Generators
- January 26, 2010 -
FDA Announces Class I Recall of Certain Infusion Set Needles
- January 26, 2010 -
FDA Approves Morphine Sulfate Oral Solution for Relief of Acute and Chronic
Pain
- January 25, 2010 -
FDA Approves New Treatment for Type 2 Diabetes
- January 25, 2010 -
FDA Approves First Percutaneous Heart Valve
- January 22, 2010 -
FDA Schedules Public Meeting on Premarket Clearance Process for Medical
Devices
- January 22, 2010 -
FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis
- January 20, 2010 -
FDA Approves Left Ventricular Assist System for Severe Heart Failure
Patients
- January 19, 2010 -
U.S. Attorney New Release: Bellevue, Washington Salon Owner Sentenced in
Connection with Unlicensed Cosmetic Treatments
- January 18, 2010 -
FDA Warns Consumers about Counterfeit Alli
- January 15, 2010 -
FDA Commissioner Addresses Nation's Health Care Professionals on H1N1
Vaccine Safety
- January 15, 2010 -
U.S. Attorney New Release: Anesthesiologist Charged With Falsifying Medical
Research
- January 14, 2010 -
FDA Health Alert for Merrick Beef Filet Squares Dog Treats Packaged and
Distributed by Merrick Pet Care
- January 14, 2010 -
FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler
- January 13, 2010 -
FDA Issues Consumer Alert on HAPPYTOT Stage 4 and Some HAPPYBABY Stage 1 &
Stage 2 Baby Foods
- January 13, 2010 -
U.S. Attorney News Release: Longmont, Colorado Man Arrested For Removing And
Replacing Labels On Gatorade Bottles
- January 12, 2010 -
FDA Unveils First Phase of Transparency Initiative
- January 11, 2010 -
FDA Approves New Drug for Rheumatoid Arthritis
- January 08, 2010 -
FDA Awards Contract to Harvard Pilgrim to Develop Pilot for Safety
Monitoring System
- January 08, 2010 -
FDA Ends Maryland Seafood Processors Pattern of Sanitary Violations
- January 08, 2010 -
FDA Requires Sybaritic, Inc. to Stop Producing Unapproved Medical Devices
- January 06, 2010 -
FDA Seizes More Than $1 Million Worth of Food from Nashville Food Processor
and Warehouse: Agency acts to prevent distribution of food from
rodent-infested facility
- January 04, 2010 -
FDA Takes Action Against New Jersey Cheese Manufacturer
|
|
|
The e-Newsletter of
What's New with CDER, CDRH & CBER
Distributed by the worlds
leader in Federal Regulations,
GMP Publications, Inc. & FDA.COM
Tel: 866-GXPNews (or 856-810-7331) Fax: 856-810-7339
http://www.gmppublications.com /
http://www.fda.com
John Cuspilich, Sr. Editor, GXPNews
If you would like to advertise in this eNewsletter, call
856-810-1825
|